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To investigate whether treating cancer patients with erythropoiesis-
stimulating agents (ESAs) would increase the mortality risk, Bennett
et al. [Journal of the American Medical Association 299 (2008) 914–
924] conducted a meta-analysis with the data from 52 phase III trials
comparing ESAs with placebo or standard of care. With a standard
parametric random effects modeling approach, the study concluded
that ESA administration was significantly associated with increased
average mortality risk. In this article we present a simple nonparamet-
ric inference procedure for the distribution of the random effects. We
re-analyzed the ESA mortality data with the new method. Our results
about the center of the random effects distribution were markedly dif-
ferent from those reported by Bennett et al. Moreover, our procedure,
which estimates the distribution of the random effects, as opposed
to just a simple population average, suggests that the ESA may be
beneficial to mortality for approximately a quarter of the study pop-
ulations. This new meta-analysis technique can be implemented with
study-level summary statistics. In contrast to existing methods for
parametric random effects models, the validity of our proposal does
not require the number of studies involved to be large. From the re-
sults of an extensive numerical study, we find that the new procedure
performs well even with moderate individual study sample sizes.
1. Introduction. Conventional meta-analysis techniques have been uti-
lized frequently to make inferences about a single parameter, for example,
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the center of the distribution of the random or fixed effects. Under the ran-
dom effects model, the procedure for estimating the mean of the random
effects proposed by DerSimonian and Laird (DL) (1986) is routinely used in
practice. Their method utilizes a linear combination of study-specific point
estimates with the weights depending on the within- and among-study vari-
ance estimates. This procedure is simple to implement and does not require
patient-level data. Its validity, however, depends heavily on the individual
study sample sizes and the number of studies [Brockwell and Gordon (2001),
Bohning et al. (2002), Sidik and Jonkman (2007) and Viechtbauer (2007)].
In addition, this and other related methods for random effects models in
meta-analysis do not provide inferences about the distribution function of
the random effects. Estimation of this distribution function or its quantile
counterpart provides valuable information for the complex risk-benefit deci-
sion on a new drug or device.
In a meta-analysis using the data from 52 phase III comparative tri-
als (ESA vs. placebo or standard of care), Bennett et al. (2008) examined
whether the erythropoiesis-stimulating agents (ESAs) for treating anemia
of cancer patients would increase the patients’ risk of mortality. The point
and 95% interval estimates of two-sample study-specific hazard ratio were
presented in Figure 2 of Bennett et al. Bennett et al. (2008) concluded that
administration of ESAs was significantly associated with increased mortality.
Using the DL method, the resulting 95% confidence interval for the mean of
the random hazard ratios (treated vs. untreated with ESA) across the studies
was (1.01, 1.20). The lower bound of the interval is barely above 1. Further-
more, it is known that the DL method can produce liberal confidence interval
estimates, that is, the true coverage level tends to be smaller (sometimes sub-
stantially) than the nominal value [Emerson, Hoaglin and Mosteller (1993),
Hardy and Thompson (1996), Brockwell and Gordon (2001, 2007) and Sidik
and Jonkman (2002)]. Therefore, the interval estimates reported by Bennett
et al. may be “too tight.” Moreover, from Figure 2 of Bennett et al., it ap-
pears that the study-specific hazard ratio estimates for 22 out of 52 trials
are less than 1, suggesting that even if the average hazard ratio is more
than 1, the ESA may not be harmful in all study populations. Last, since
the DL method is based on a weighted average of hazard ratio estimates,
the resulting interval estimates may be sensitive to outliers.
In this article we propose a simple inference procedure for the percentiles
of the random effects distribution based on study-level data without assum-
ing a parametric form of the distribution. We re-analyzed the mortality data
reported in Bennett et al. (2008). The resulting 95% confidence interval for
the median of the random hazard ratios was (0.94, 1.26). The 95% confi-
dence interval for the lower quartile of the random hazard ratios was (0.70,
0.99), indicating that, in approximately a quarter of the study populations,
ESA treatment may reduce mortality. In contrast to all existing methods,
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which can only handle inference for the center of the random effects distri-
bution, the new proposal does not require the number of studies to be large.
The new proposal is theoretically valid when the sample sizes of individ-
ual studies are large. Through an extensive numerical study, we find that
the new method performs well even with moderate individual study sample
sizes. On the other hand, the DL method tends to give liberal confidence
interval estimators, that is, their coverage levels can be markedly smaller
than the nominal value.
2. Interval estimates for percentiles of the random effects distribution.
Consider a typical two-level hierarchical model. Let Π′ = (Θ,Λ′) be a row
vector of random parameters, where Θ is a univariate parameter of inter-
est and Λ is a finite- or infinite-dimensional vector of nuisance parameters.
Let G(·) be the continuous, completely unspecified distribution function of
Θ. Given an unobservable realization Π, a data set X is generated. Let
{Πk,Xk}, k = 1, . . . ,K, be K independent copies of {Π,X}. The problem
is how to make inferences, for instance, about the median µ of G(·) with
{Xk, k = 1, . . . ,K}. As an example, consider the case with K 2× 2 tables
and let Θk be the log-risk-ratio or risk difference for the kth table. Here, the
nuisance parameter Λk consists of the underlying event rate for the “control”
group and the sample size for the kth study nk.
If we can observe {Θk, k = 1, . . . ,K}, a simple nonparametric estimator
for µ is the sample median. Exact confidence intervals for µ can be obtained
by inverting a sign test for the null hypothesis that the median is µ0. Under
H0 :µ= µ0, consider
T (µ0) =
K∑
k=1
Bk,(1)
where Bk = I(Θk <µ0)− I(Θk > µ0) and I(·) is the indicator function. The
null distribution of T (µ0) can be generated by
T ∗ =
K∑
i=1
∆k where ∆k =
{
1, with probability 0.5,
−1, otherwise.
(2)
Suppose that, given Πk, Θˆk is a consistent estimator for Θk based on the
data Xk. To test H0, one may replace Θk in (1) with Θˆk. This results in the
test statistic
T˜ (µ0) =
K∑
k=1
Bˆk =
K∑
k=1
{I(Θˆk < µ0)− I(Θˆk > µ0)}.(3)
When the sample size nk for each individual study is large, we can make
inferences about the median by comparing the observed value of (3) to the
distribution of (2).
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Now, the test based on (3) does not take into account the precision of the
estimator Θˆk. It gives equal weight to each individual study. For the kth
study, suppose that the variance σˆ2k of Θˆk is large relative to the distance
between Θk and µ0. Then the likelihood of the unobservable Θk < µ0 can be
quite close to 1/2 (like tossing a fair coin). Therefore, the noise generated
from such an unstable Bˆk may well outweigh its added value to the power
of the test based on T˜ (µ0). On the other hand, if σˆ
2
k is small and Θˆk < µ0,
the likelihood of Θk <µ0 would be closer to 1.
This motivates us to modify test statistic (3) by putting weight wk on Bˆk.
Here, wk is a measure of likelihood of the event Θk < µ0, for example, the ob-
served coverage level of the interval (−∞, µ0) for the realized Θk. When the
individual study size nk is large, and the distribution of Θˆk conditional on
Πk is approximately normal with mean Θk and variance σˆ
2
k, where nkσˆ
2
k con-
verges to a constant, this coverage level is approximately Φ((µ0 − Θˆk)/σˆk),
where Φ is the distribution function of the standard normal. Let the resulting
test statistic be
Tˆ (µ0) =
K∑
k=1
|Φ((µ0 − Θˆk)/σˆk)− 1/2|Bˆk.(4)
In the Appendix we show that, in probability, for any given µ,
|Φ((µ− Θˆk)/σˆk)− 1/2|Bˆk −Bk/2→ 0 as nk →∞.(5)
It follows that, for fixed K, for large nk, k = 1, . . . ,K, the distribution of
Tˆ (µ0) approximates that of T (µ0). This approximation, however, is rather
discrete; and for moderate sample sizes, the resulting confidence intervals
for µ do not have adequate coverage levels in our numerical study (Section
4). An alternative way to generate an approximation to the null distribution
of Tˆ (µ0) is to use
Tˆ ∗(µ0) =
K∑
k=1
|Φ((µ0 − Θˆk)/σˆk)− 1/2|∆k.(6)
Here, the ∆k’s are the only random quantities and are analogous to the
random multipliers used in the wild bootstrap [Wu (1986)]. The weight
from the kth study is multiplied by ∆k, which is 1 or −1 with probability
0.5 and is generated by the analyst independently of the observed data. In
the Appendix, we also justify the asymptotic validity of the test based on
(4) and (6). Confidence intervals for µ can be obtained by inverting this
test. In contrast to other methods, the new proposal does not require the
number of studies (K) to be large. In Section 4 we show empirically that
the new interval estimation procedure performs well even when the sample
sizes (nk) are not large.
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The above proposal can be generalized easily to make inferences about
certain percentiles of the distribution G(·). Specifically, let us hypothesize
that the 100pth percentile is µ0. As for the median, define Bk = I(Θk <
µ0)− I(Θk > µ0), and obtain Bˆk by replacing Θk in Bk with Θˆk. The test
statistic is given by
Tˆp(µ0) =
K∑
k=1
|Φ((µ0 − Θˆk)/σˆk)− 1/2|Bˆk,(7)
and the null distribution is generated by
Tˆ ∗p (µ0) =
K∑
k=1
|Φ((µ0 − Θˆk)/σˆk)− 1/2|∆k,(8)
where ∆k = 1 with probability p and =−1 with probability 1− p. Let the
resulting test statistic corresponding to (3) be denoted by T˜p(µ0). Confidence
intervals for the 100pth percentile can then be obtained by inverting the
conditional test accordingly.
3. Safety meta-analysis of erythropoiesis-stimulating agents. We re-ana-
lyzed the data reported in Bennett et al. (2008) using the new proposal. Here
K = 52, and for the kth study, Θk was the log-hazard ratio and Θˆk was its
estimate. Since the patient-level data were not available, we approximated
the standard error estimate of Θˆk by one-fourth of the reported length of
the 95% confidence interval (converted to the log-scale). The 95% confi-
dence interval for the median of the distribution of the random hazard ratio
(exp(Θ)) was (0.94,1.21) based on the test statistic Tˆ (·) and (6). The cor-
responding interval based on the indicator functions {I(Θˆk < µ)} via T˜ (·)
was (0.90,1.26), which was wider than the above interval. The 95% confi-
dence interval for the mean of the random effects distribution reported in
Bennett et al. (2008) using the DL method was (1.01,1.20). In the next
section we show that the empirical coverage levels of the DL method can be
substantially lower than their nominal counterparts even when the number
of studies is not that small (say, K = 40).
The 95% intervals for the 25th and 75th percentiles based on (7) and (8)
were (0.70, 0.99) and (1.18, 1.48), respectively. The counterparts based on
T˜p(·) were (0.49, 0.93) and (1.25, 1.72). Again, the intervals based on Tˆp(·)
were shorter than those with T˜p(·). Note that the upper bound of the 95%
interval for the 25th percentile was smaller than 1, which suggested that,
approximately, for a quarter of the study populations, their average hazard
ratios for the ESA versus the control were most likely less than one. That is,
on average, the patients in these study populations may benefit from taking
ESA with respect to mortality.
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Further investigation to identify characteristics of these trials would be
informative for identifying future cancer patients who would benefit from
the ESAs through reduction of blood cell transfusions and improved quality
of life. On the other hand, it is crucial to identify future patients who would
have unacceptable toxicity risks.
Bennett et al. (2008) also separately evaluated cancer-related anemia with
six studies (see the top portion of Figure 2 in Bennett et al.) and investigated
whether ESAs would increase the risk of a venous thromboembolism event
(VTE) from 38 comparative phase III trials. The results obtained using the
new proposal are reported in the supplemental article [Wang et al. (2009)].
4. Numerical studies to evaluate performance of the new proposal. We
conducted extensive numerical studies to examine the performance of the
proposed interval estimation procedure for the percentiles of the random
effects model under various practical settings. The existing random effects
methods for meta-analysis have focused on making inferences about the
mean of the random effects distribution. To the best of our knowledge, no
other methods address the same issue as our proposed procedure does. Our
numerical studies included the DL interval estimation method, the method
proposed by Sidik and Jonkman (2002) (SJ), and the one based on T˜ (·)
for comparisons. We considered cases with binary or continuous responses,
various symmetric or asymmetric random effects distributions, and a wide
range of study sample sizes and number of studies. From the results of our
numerical investigation, we find that the new proposal performs well with
respect to the confidence interval coverage level and length. The DL (or
SJ) method tends to be liberal, that is, the empirical coverage levels can be
markedly lower than their nominal counterparts. The procedure based on
the test statistic T˜ (·) produces confidence intervals whose average lengths
are uniformly wider than those with our method. For percentiles other than
the median, the method based on T˜p(·) may have under-coverage.
Specifically, in our numerical studies, we first considered meta-analysis
for multiple 2× 2 tables under settings similar to the meta-analysis of VTE
rates in Figure 3 of Bennett et al. (2008). There are 41 studies listed and
the raw data are available for 40 studies. We let Θk = log(P1k/P0k) be the
log-relative risk for the kth study, where P1k and P0k are the underlying
event rates for the ESA and control groups, respectively. We then assumed
that the random vectors (logit(P0k), logit(P1k))
′ were a random sample of
size K from a bivariate normal, whose mean η and variance–covariance ma-
trix Σ were estimated by their sample counterparts via the observed rates
in Figure 3 of Bennett et al. (2008). We used the conventional 0.5 con-
tinuity correction for studies with zero cells. The resulting sample means
and variance–covariance matrix are (−3.56,−2.86)′ and
(
0.90
0.62
0.62
1.10
)
, respec-
tively. The density of Θ is given in Figure 1 [panel (a)], which appears to
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Fig. 1. The true density functions for the random log-relative-risk parameter for the
simulation study.
be quite symmetric. For each realization {(P0k, P1k)
′, k = 1, . . . ,K}, we gen-
erated the corresponding set of 2 × 2 tables. We then used DL, SJ, Tˆ (·)
and T˜ (·) to construct 95% confidence intervals for the median of the distri-
bution of Θ. For each realized data set, we excluded studies with 0–0 cells
(that is, no events occurred in either group), and used the 0.5 continuity
correction for studies with one zero cell. The average empirical coverage lev-
els and the median interval lengths were obtained from 2000 realized data
sets.
Under the same setting, we repeated this process with K = 40, 30, 20,
10 and 6. For each K, the sample sizes came from the first K studies listed
in Figure 3 of Bennett et al. (2008). The results are summarized in Table
1 (top half). The average coverage levels for our proposed method, Tˆ (·),
range from 0.94 to 0.95. On the other hand, the average empirical coverage
level can be as low as 0.86 for the DL method, and 0.88 for the SJ method.
The median lengths of the intervals obtained via Tˆ (·) are uniformly smaller
than those of the procedure using T˜ (·). In Table 2 (top half), we report the
results for the 25th and 75th percentiles. Again our proposal behaves well,
but the one with T˜p(·) may not have the correct coverage level.
We also considered rather asymmetric random effects distributions. For
example, we considered a bivariate beta distribution for {(P0k, P1k)
′, k =
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Table 1
Empirical coverage levels (ECL) and median lengths (ML) of 95% interval estimates for
median based on DerSimonian–Laird (DL), Sidik and Jonkman (SJ), Tˆ (·) and T˜ (·) with
a bivariate logit-normal or a bivariate beta distribution for the two underlying random
event rates
Number of
studies, K
DL SJ Tˆ (·) T˜ (·)
ECL ML ECL ML ECL ML ECL ML
Bivariate logit-normal
40 86% 0.62 88% 0.65 94% 0.72 95% 0.90
30 88% 0.71 91% 0.75 94% 0.83 95% 1.03
20 88% 0.85 91% 0.90 94% 1.00 95% 1.23
10 88% 1.18 94% 1.36 95% 1.54 97% 2.15
6 91% 1.57 97% 2.06 95% 2.29 97% 2.89
Bivariate beta
40 87% 0.40 89% 0.42 95% 0.52 96% 0.65
30 88% 0.46 90% 0.48 95% 0.61 96% 0.75
20 90% 0.55 92% 0.59 96% 0.75 96% 0.91
10 91% 0.76 93% 0.89 96% 1.10 98% 1.56
6 88% 1.00 94% 1.30 95% 1.58 97% 2.10
1, . . . ,40} via three independent gamma random variables with a common
unit scale parameter and shape parameters of 2, 8 and 10, respectively [Olkin
and Liu (2003)]. The resulting density function of the random parameter
Θ, the log-relative risk, is given in Figure 1 [panel (b)]. Under the same
setting as the previous simulation, the results are reported in the bottom
half portions of Tables 1 and 2. Again, the new procedure performs well. The
DL (or SJ) method still has coverage problems. Although the DL method
produces confidence interval estimates for the mean of G(·), not the median,
its empirical coverage for the mean was also lower than the nominal 95%.
For example, when K = 40, the coverage of DL for the mean was only 64%.
Although our method assumes that the random effects distribution is con-
tinuous, we also considered cases with fixed effects models in our numerical
study. For example, we let (P0k, P1k) = (0.1,0.2), k = 1, . . . ,K. The results
are summarized in Table 3. For this case, the DL method has correct cover-
age level for most scenarios under which our interval estimation procedure is
comparable with the DL method with respect to efficiency, which is reflected
in the interval length. We also studied the performance of our method for
Θk = P1k − P0k, the risk difference for the kth study. The results were very
similar to those for the relative risk.
Our numerical studies with continuous responses yielded similar results.
We summarize the study settings and the results in the supplemental article
[Wang et al. (2009)]. We expect similar results for censored time to event ob-
servations, where hazard ratios are used for treatment effect measurements.
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Table 2
Empirical coverage levels (ECL) and median lengths (ML) of 95% confidence intervals
for the 25th and 75th percentiles based on Tˆp(·) and T˜p(·) with a bivariate logit-normal or
a bivariate beta distribution for the two underlying random event rates
25th percentile 75 percentile
Number of
studies, K
Tˆp(·) T˜p(·) Tˆp(·) T˜p(·)
ECL ML ECL ML ECL ML ECL ML
Bivariate logit-normal
40 95% 0.86 86% 1.16 95% 0.81 92% 0.92
35 96% 0.91 88% 1.21 96% 0.86 90% 1.02
30 96% 1.00 90% 1.37 96% 0.94 91% 1.12
25 96% 1.12 90% 1.49 97% 1.06 92% 1.23
20 96% 1.24 92% 1.52 97% 1.16 92% 1.32
Bivariate beta
40 96% 0.48 93% 0.55 96% 0.73 92% 0.96
35 96% 0.52 95% 0.61 96% 0.78 93% 1.04
30 95% 0.56 94% 0.64 96% 0.85 93% 1.07
25 96% 0.62 93% 0.65 96% 0.94 92% 1.10
20 96% 0.72 95% 0.80 96% 1.37 95% 1.37
Table 3
Empirical coverage levels (ECL) and median lengths (ML) of 95% interval estimates for
median based on DerSimonian–Laird (DL), Tˆ (·) and T˜ (·) under a fixed effect model (the
underlying event rates are 0.1 and 0.2)
Number of
studies, K
DL Tˆ (·) T˜ (·)
ECL ML ECL ML ECL ML
40 92% 0.24 95% 0.27 96% 0.35
30 94% 0.26 95% 0.30 96% 0.39
20 95% 0.30 95% 0.35 97% 0.45
10 97% 0.47 96% 0.57 98% 0.84
6 96% 0.75 95% 1.03 97% 1.34
5. Discussion. In this article we present a simple nonparametric interval
estimation procedure for percentiles of the random effects distribution. Ran-
dom effects meta-analysis is frequently employed in medical research. How-
ever, the validity of the most popular method (DL) and its variations [Hardy
and Thompson (1996), Biggerstaff and Tweedie (1997), Hartung (1999),
Hartung and Knapp (2001a, 2001b) and DerSimonian and Kacker (2007)] is
not clear when the number of studies is not large or the parametric assump-
tion for the random effects is violated. An excellent review on meta-analysis
with the random effects model is given by Sutton and Higgins (2008). In
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contrast to previous methods, our proposal does not require the number of
studies to be large. The new proposal is valid provided the individual study
sample sizes are large.
In addition, if the random effects distribution is symmetric and the exact
distribution of Θˆk, k = 1, . . . ,K, conditional on Πk, is symmetric around the
unknown fixed realized Θk, it is easy to show that the resulting interval es-
timators based on Tˆ (·) for the median (or mean) are valid without requiring
the sizes of the individual studies or the number of studies to be large. For
instance, under the usual two-sample location shift model with continuous
response variable, let Θ be the location shift parameter of interest. Then,
the two-sample rank estimator Θˆ is symmetric around Θ under rather mild
conditions [Lehmann (1975), page 86]. If the unspecified random effects dis-
tribution is symmetric around µ, one can use our procedure to obtain exact
confidence intervals for µ. To examine the performance of the method in
this setting, we conducted a simulation study, described in detail in the
supplemental article [Wang et al. (2009)].
The proposed procedure can be implemented with study level summary
statistics. When patient level data are available, various novel procedures
have been studied for mixed effects regression models for continuous, dis-
crete or censored event time observations [Laird and Ware (1982), Hougaard
(1995), Hogan and Laird (1997), Henderson, Diggle and Dobson (2000),
Lam, Lee and Leung (2002), Nelder, Lee and Pawitan (2006), Cai, Cheng
and Wei (2002), Zeng and Lin (2007) and Zeng, Lin and Lin (2008)]. To the
best of our knowledge, all of the existing asymptotic procedures for mixed
effects models assume that the number of studies is large.
In the current practice of meta-analysis, inferences are made only for the
“center” of the random effects distribution. A conclusion on the risk or ben-
efit from an intervention based solely on an estimated center of the random
effects distribution provides limited information and is usually not sufficient.
If the number of studies involved is not small, we highly recommend esti-
mating this distribution or its percentiles as proposed in this article.
Under the fixed effects model, this distribution has a single unknown
mass point. The standard estimation procedure for such a fixed parameter
value utilizes a weighted average of study-specific point estimates. For an-
alyzing multiple 2× 2 tables, the most commonly used procedures are the
Mantel–Haenszel [Mantel and Haenszel (1959)] and Peto methods [Yusuf et
al. (1985)]. These methods are valid when the number of studies and each
individual study sample size are large. Moreover, when the event rate is
small, these standard methods may not perform well. For the fixed effects
model, Tian et al. (2009) proposed a general exact interval estimation proce-
dure that combines study-specific exact confidence intervals instead of point
estimates. If the fixed effects model is approximately correct, the existing
interval procedures for the common parameter value µ may be more efficient
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than those developed under the random effects model. The standard hetero-
geneity tests generally do not have the power to detect violations of the fixed
effects modeling assumption. Therefore, in practice, sensitivity analyses with
both random and fixed effects models are highly recommended.
APPENDIX: JUSTIFICATION FOR THE CONDITIONAL TEST Tˆ (·)
BASED ON THE APPROXIMATION GENERATED BY Tˆ ∗(·)
Let Dk = |Φ((µ− Θˆk)/σˆk)− 1/2|Bˆk −Bk/2. We show that Dk goes to 0,
in probability, as nk →∞. Here, the probability is generated by the ran-
dom element (Xk,Πk). For any fixed positive constant c, first we show that
pr(|Dk| ≥ c|Πk)→ 0 for any given Πk with Θk 6= µ. To this end, consider two
cases. First, if Θk < µ, then conditional on Πk,
|Dk|= |Φ((µ− Θˆk)/σˆk)− 1|= 1−Φ((µ−Θk)/σˆk + (Θk − Θˆk)/σˆk).
As nk →∞, (µ−Θk)/σˆk →∞ in probability, and (Θk − Θˆk)/σˆk →N(0,1)
in distribution. Therefore, for any c > 0, we can find N such that, when
nk >N , pr((µ−Θk)/σˆk + (Θk − Θˆk)/σˆk ≤Φ
−1(1− c))< c, which is equiva-
lent to pr(Φ((µ− Θˆk)/σˆk)< 1− c) = pr(|Dk| ≥ c)< c. Therefore, pr(|Dk| ≥
c |Πk)→ 0. Similarly, if Θk > µ, we can show that pr(|Dk| ≥ c |Πk)→ 0 as
nk →∞. Therefore, pr(|Dk| ≥ c |Πk)→ 0 for any Πk such that Θk 6= µ.
This, coupled with the fact that G(·) is continuous, implies that pr(|Dk| ≥
c) = EΠk{pr(|Dk| ≥ c | Πk)} → 0 for any c by the dominated convergence
theorem. Therefore,Dk → 0 in probability as nk →∞. It follows that |Tˆ (µ)−∑K
k=1Bk/2| → 0, in probability, as min{n1, . . . , nK}→∞.
Similarly, since
||Φ((µ− Θˆk)/σˆk)− 1/2|∆k − |I(Θk < µ)− 1/2|∆k| ≤ |Dk|,
one can show that Tˆ ∗(µ)−
∑K
k=1 |I(Θk < µ)− 1/2|∆k → 0, in probability,
as min{n1, . . . , nK}→∞, where
∆k =
{
1, with probability p,
−1, with probability 1− p,
for the 100pth percentile and is independent of the data. Therefore, for any
t and positive c,
pr{(Xk ,Πk)k=1,...,K}
(∣∣∣∣∣pr(Tˆ ∗(µ)≤ t|(Xk,Πk)k=1,...,K)− pr
(
K∑
k=1
∆k/2≤ t
)∣∣∣∣∣≥ c
)
≤ c,
when min{n1, . . . , nK} is large. This, coupled with the fact that
∑K
k=1Bk/2∼∑K
k=1∆k/2 under the null hypothesis that the 100pth percentile of Θk is µ,
implies that one can approximate the null distribution of Tˆ (µ) by the dis-
tribution of Tˆ ∗(µ) conditional on the observed data.
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SUPPLEMENTARY MATERIAL
Additional examples, simulation results and computer codes (DOI:
10.1214/09-AOAS280SUPP; .pdf). We present the results for the mortal-
ity data set restricted to the six trials for anemia of cancer and the results
for the venous thromboembolism rates data set in Bennett et al. (2008)
using the proposed approach, report the simulation results for continuous
responses and for the setting where the sample sizes for individual studies are
small, and provide R codes for implementation of the proposed procedure.
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